Tag:

Bill and Melinda Gates Foundation

Latest Headlines

Latest Headlines

Gates Foundation backs Ebola trials for plasma-based and other treatments

Blood from Ebola patients who have survived infection has been used to treat patients actively fighting the virus. Now the Bill & Melinda Gates Foundation is backing efforts to test the efficacy of and scale up the production of convalescent plasma and other potential treatments in the field.

Device that performs hundreds of tests with a single drop of blood wins Nokia Sensing Xchallenge

The DNA Medicine Institute, developer of a diagnostic device that can perform hundreds of clinical lab tests with a single drop of blood, won the Nokia Sensing Xchallenge for promising medical sensing technologies.

Gates Foundation adds $50M to help speed Ebola drug development efforts

As government health agencies and industry players ramp up efforts to bring experimental therapies as quickly as possible to people affected by the Ebola outbreak in West Africa, the Bill and Melinda Gates Foundation said Wednesday that it is putting up $50 million to aid drug development and outbreak response efforts.

Gates, Wellcome bet $40M on Kymab's antibody tech

Cambridge, U.K.'s Kymab touts its drug development platform as an ideal way to spotlight new antibodies, and some bright minds would seem to agree, as the Wellcome Trust and Bill and Melinda Gates Foundation have teamed up on a $40 million round for the biotech.

Genentech's ex-R&D boss takes the reins at the Gates Foundation

The Bill & Melinda Gates Foundation has picked Susan Desmond-Hellmann to lead as its next CEO, bringing the Genentech veteran's years of experience in drug development and academia to one of the largest charitable organizations in the world.

Sanofi, Glaxo sign up for vaccine R&D projects under new Gates initiative

In its joint venture, Glaxo will front $1.8 million for work on the thermostability of vaccines. GSK will set out to make adjuvants--used to boost the effectiveness of vaccines--more heat stable. The project fits within the broad scope of work attempting to break the "cold chain" supply process that requires vaccines to remain refrigerated--a big challenge for developing countries.

Zyomyx pulls in $12M to advance low-cost HIV Dx to finish line

Two major milestones will accelerate Zyomyx's push to get its point-of-care HIV diagnostic test out into the developing world. The company sealed a deal for $12 million in fresh financing and also agreed to make Mylan its distribution partner in a move that will help the test reach global, emerging markets.

WHO approves low-tech Israeli circumcision device

PrePex, a simple nonsurgical circumcision device made of a rubber band and a grooved ring, has gained crucial World Health Organization approval.

Swiss team envisions cheap, durable Dx imaging for Africa

Researchers at Switzerland's Federal Institute of Technology in Lausanne are developing an inexpensive, easy-to-use radiology machine that's functional in sub-Saharan Africa and elsewhere in the developing world where conditions are pretty rough.

Alere snags up to $42.2M from Gates Foundation for TB Dx

Diagnostics magnate Alere has hooked up with the Bill and Melinda Gates Foundation to develop a tuberculosis assay and support its point-of-care HIV test.